Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model
Deregulation of NOTCH2 signaling is implicated in a wide variety of human neoplasias. The current concept of targeting NOTCH is based on using gamma secretase inhibitors (GSI) to regulate the release of the active NOTCH intracellular domain. However, the clinical outcome of GSI remains unsatisfactor...
Main Authors: | Rainer Hubmann, Wolfgang Sieghart, Susanne Schnabl, Mohammad Araghi, Martin Hilgarth, Marlies Reiter, Dita Demirtas, Peter Valent, Christoph Zielinski, Ulrich Jäger, Medhat Shehata |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00319/full |
Similar Items
-
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL
by: Rainer Hubmann, et al.
Published: (2020-06-01) -
Integration of In Silico and In Vitro Analysis of Gliotoxin Production Reveals a Narrow Range of Producing Fungal Species
by: Sergio Redrado, et al.
Published: (2022-03-01) -
Cytotoxicity and genotoxicity of gliotoxin on human lymphocytes in vitro
by: Mohammed Adel Nouri, et al.
Published: (2015-07-01) -
Gliotoxin elicits immunotoxicity in the early innate immune system of ducks
by: Zhengkai Wei, et al.
Published: (2024-06-01) -
Control of Root-rot Diseases of Phaseolus vulgaris Using Gliotoxin
by: Aliaa, R. E.
Published: (2008-01-01)